20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Systemic immune-inflammation index for predicting prognosis of colorectal cancer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          AIM

          To investigate the clinical significance of preoperative systemic immune-inflammation index (SII) in patients with colorectal cancer (CRC).

          METHODS

          A retrospective analysis of 1383 cases with CRC was performed following radical surgery. SII was calculated with the formula SII = (P × N)/L, where P, N, and L refer to peripheral platelet, neutrophil, and lymphocyte counts, respectively. The clinicopathological features and follow-up data were evaluated to compare SII with other systemic inflammation-based prognostic indices such as the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in patients with CRC.

          RESULTS

          The optimal cut-off point for SII was defined as 340. The overall survival (OS) and disease-free survival (DFS) were better in patients with low NLR, PLR, and SII ( P < 0.05). The SII was an independent predictor of OS and DFS in multivariate analysis. The area under the receiver-operating characteristics (ROC) curve for SII (0.707) was larger than those for NLR (0.602) and PLR (0.566). In contrast to NLR and PLR, SII could effectively discriminate between the TNM subgroups.

          CONCLUSION

          SII is a more powerful tool for predicting survival outcome in patients with CRC. It might assist the identification of high-risk patients among patients with the same TNM stage.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found

          Inflammation and cancer: advances and new agents.

          Tumour-promoting inflammation is considered one of the enabling characteristics of cancer development. Chronic inflammatory disease increases the risk of some cancers, and strong epidemiological evidence exists that NSAIDs, particularly aspirin, are powerful chemopreventive agents. Tumour microenvironments contain many different inflammatory cells and mediators; targeting these factors in genetic, transplantable and inducible murine models of cancer substantially reduces the development, growth and spread of disease. Thus, this complex network of inflammation offers targets for prevention and treatment of malignant disease. Much potential exists in this area for novel cancer prevention and treatment strategies, although clinical research to support targeting of cancer-related inflammation and innate immunity in patients with advanced-stage cancer remains in its infancy. Following the initial successes of immunotherapies that modulate the adaptive immune system, we assert that inflammation and innate immunity are important targets in patients with cancer on the basis of extensive preclinical and epidemiological data. The adaptive immune response is heavily dependent on innate immunity, therefore, inhibiting some of the tumour-promoting immunosuppressive actions of the innate immune system might enhance the potential of immunotherapies that activate a nascent antitumour response.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.

            Accumulating evidences indicate cancer-triggered inflammation plays a pivotal role in carcinogenesis. Systematic inflammatory response biomarkers are considered as potential prognostic factors for improving predictive accuracy in colorectal cancer (CRC). Preoperative neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (d-NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte- to-monocyte ratio (LMR) were investigated and compared in 205 surgical CRC patients. ROC curve was applied to determine thresholds for four biomarkers, and their prognostic values were assessed using Kaplan-Meier curve, univariate and multivariate COX regression models. Moreover, a number of risk factors were used to form nomograms for evaluating risk of survival, and Harrell's concordance index (c-index) was used to evaluate predictive accuracy. Results showed that elevated NLR was significantly associated with diminished recurrent-free survival (RFS), overall survival (OS) and cancer-specific survival (CSS) in surgical CRC patients. Moreover, multivariate COX analysis identified elevated NLR as an independent factor for poor RFS (P < 0.001, HR 2.52, 95% CI 1.65-3.83), OS (P < 0.001, HR 2.73, 95% CI 1.74-4.29) and CSS (P < 0.001, HR 2.77, 95% CI 1.72-4.46). Additionally, predictive nomograms including NLR for RFS, OS and CSS could be more effective in predicting RFS (c-index: 0.810 vs. 0.656), OS (c-index: 0.809 vs. 0.690) and CSS (c-index: 0.802 vs. 0.688) in surgical CRC patients, respectively. These findings indicate that preoperative elevated NLR can be considered as an independent prognostic biomarker for RFS, OS and CSS. Nomograms containing NLR provide improved accuracy for predicting clinical outcomes in surgical CRC patients under surgery resection.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.

              The prognostic nutritional index is reportedly related to postoperative outcomes.
                Bookmark

                Author and article information

                Contributors
                Journal
                World J Gastroenterol
                World J. Gastroenterol
                WJG
                World Journal of Gastroenterology
                Baishideng Publishing Group Inc
                1007-9327
                2219-2840
                14 September 2017
                14 September 2017
                : 23
                : 34
                : 6261-6272
                Affiliations
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China. chenchqi@ 123456mail.sysu.edu.cn
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Gastric Cancer Center, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
                Author notes

                Author contributions: Chen JH and Zhai ET contributed equally to this study, and both conceptualized and designed the study, analyzed and interpreted the data, drafted the manuscript, and critically revised the manuscript for important intellectual content; Yuan YJ, Wu KM, Xu JB, Peng JJ and He YL participated in data acquisition and statistical analysis; Chen CQ and Cai SR supervised the whole study and monitored the standard surgical operations; all the authors took part in the surgical treatment of colorectal cancer.

                Supported by National Nature Science Foundation of China, No. 81672343 and No. 81372341; Guangdong Province Natural Science Fund of China, No. 2014A030310111; and Guangdong Science and Technology Plan Project of China, No. 2013B021800131and No. 201604020003.

                Correspondence to: Chuang-Qi Chen, MD, Gastrointestinal Surgery Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China. chenchqi@ 123456mail.sysu.edu.cn

                Telephone: +86-87-755766-6211 Fax: +86-87-755766-6211

                Article
                jWJG.v23.i34.pg6261
                10.3748/wjg.v23.i34.6261
                5603492
                28974892
                328080bf-4ef8-4493-9225-8d0683552356
                ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.

                This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

                History
                : 25 March 2017
                : 3 June 2017
                : 4 July 2017
                Categories
                Retrospective Cohort Study

                colorectal cancer,systemic immune-inflammation index,neutrophil-lymphocyte ratio,platelet-lymphocyte ratio,prognosis

                Comments

                Comment on this article